Literature DB >> 34737399

Mining for encrypted peptide antibiotics in the human proteome.

Marcelo D T Torres1,2,3, Marcelo C R Melo1,2,3, Orlando Crescenzi4, Eugenio Notomista5, Cesar de la Fuente-Nunez6,7,8.   

Abstract

The emergence of drug-resistant bacteria calls for the discovery of new antibiotics. Yet, for decades, traditional discovery strategies have not yielded new classes of antimicrobial. Here, by mining the human proteome via an algorithm that relies on the sequence length, net charge, average hydrophobicity and other physicochemical properties of antimicrobial peptides, we report the identification of 2,603 encrypted peptide antibiotics that are encoded in proteins with biological function unrelated to the immune system. We show that the encrypted peptides kill pathogenic bacteria by targeting their membrane, modulate gut and skin commensals, do not readily select for bacterial resistance, and possess anti-infective activity in skin abscess and thigh infection mouse models. We also show, in vitro and in the two mouse models of infection, that encrypted antibiotic peptides from the same biogeographical area display synergistic antimicrobial activity. Our algorithmic strategy allows for the rapid mining of proteomic data and opens up new routes for the discovery of candidate antibiotics.
© 2021. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34737399     DOI: 10.1038/s41551-021-00801-1

Source DB:  PubMed          Journal:  Nat Biomed Eng        ISSN: 2157-846X            Impact factor:   25.671


  39 in total

1.  Antimicrobial peptides of multicellular organisms.

Authors:  Michael Zasloff
Journal:  Nature       Date:  2002-01-24       Impact factor: 49.962

2.  Antimicrobial potency of cationic antimicrobial peptides can be predicted from their amino acid composition: Application to the detection of "cryptic" antimicrobial peptides.

Authors:  Katia Pane; Lorenzo Durante; Orlando Crescenzi; Valeria Cafaro; Elio Pizzo; Mario Varcamonti; Anna Zanfardino; Viviana Izzo; Alberto Di Donato; Eugenio Notomista
Journal:  J Theor Biol       Date:  2017-02-17       Impact factor: 2.691

Review 3.  Next-generation precision antimicrobials: towards personalized treatment of infectious diseases.

Authors:  Cesar de la Fuente-Nunez; Marcelo Dt Torres; Francisco Jm Mojica; Timothy K Lu
Journal:  Curr Opin Microbiol       Date:  2017-06-14       Impact factor: 7.934

Review 4.  Toward computer-made artificial antibiotics.

Authors:  Marcelo Der Torossian Torres; Cesar de la Fuente-Nunez
Journal:  Curr Opin Microbiol       Date:  2019-05-11       Impact factor: 7.934

5.  Gut microbiota. Antimicrobial peptide resistance mediates resilience of prominent gut commensals during inflammation.

Authors:  T W Cullen; W B Schofield; N A Barry; E E Putnam; E A Rundell; M S Trent; P H Degnan; C J Booth; H Yu; A L Goodman
Journal:  Science       Date:  2015-01-09       Impact factor: 47.728

6.  A new genomic blueprint of the human gut microbiota.

Authors:  Alexandre Almeida; Alex L Mitchell; Miguel Boland; Samuel C Forster; Gregory B Gloor; Aleksandra Tarkowska; Trevor D Lawley; Robert D Finn
Journal:  Nature       Date:  2019-02-11       Impact factor: 49.962

Review 7.  Synthetic Biology and Computer-Based Frameworks for Antimicrobial Peptide Discovery.

Authors:  Marcelo D T Torres; Jicong Cao; Octavio L Franco; Timothy K Lu; Cesar de la Fuente-Nunez
Journal:  ACS Nano       Date:  2021-02-04       Impact factor: 15.881

8.  In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design.

Authors:  William F Porto; Luz Irazazabal; Eliane S F Alves; Suzana M Ribeiro; Carolina O Matos; Állan S Pires; Isabel C M Fensterseifer; Vivian J Miranda; Evan F Haney; Vincent Humblot; Marcelo D T Torres; Robert E W Hancock; Luciano M Liao; Ali Ladram; Timothy K Lu; Cesar de la Fuente-Nunez; Octavio L Franco
Journal:  Nat Commun       Date:  2018-04-16       Impact factor: 14.919

9.  DRAMP 2.0, an updated data repository of antimicrobial peptides.

Authors:  Xinyue Kang; Fanyi Dong; Cheng Shi; Shicai Liu; Jian Sun; Jiaxin Chen; Haiqi Li; Hanmei Xu; Xingzhen Lao; Heng Zheng
Journal:  Sci Data       Date:  2019-08-13       Impact factor: 6.444

10.  DBAASP v.2: an enhanced database of structure and antimicrobial/cytotoxic activity of natural and synthetic peptides.

Authors:  Malak Pirtskhalava; Andrei Gabrielian; Phillip Cruz; Hannah L Griggs; R Burke Squires; Darrell E Hurt; Maia Grigolava; Mindia Chubinidze; George Gogoladze; Boris Vishnepolsky; Vsevolod Alekseyev; Alex Rosenthal; Michael Tartakovsky
Journal:  Nucleic Acids Res       Date:  2015-11-17       Impact factor: 16.971

View more
  6 in total

Review 1.  Molecular tools for probing the microbiome.

Authors:  Marcelo Der Torossian Torres; Cesar de la Fuente-Nunez
Journal:  Curr Opin Struct Biol       Date:  2022-08-16       Impact factor: 7.786

Review 2.  Deep generative models for peptide design.

Authors:  Fangping Wan; Daphne Kontogiorgos-Heintz; Cesar de la Fuente-Nunez
Journal:  Digit Discov       Date:  2022-03-31

3.  An Efficient Evaluation System Accelerates α-Helical Antimicrobial Peptide Discovery and Its Application to Global Human Genome Mining.

Authors:  Licheng Liu; Caiyun Wang; Mengyue Zhang; Zixuan Zhang; Yingying Wu; Yixuan Zhang
Journal:  Front Microbiol       Date:  2022-04-25       Impact factor: 6.064

4.  Editorial: Antimicrobial Peptides: Molecular Design, Structure-Function Relationship, and Biosynthesis Optimization.

Authors:  Ya Hao; Jianhua Wang; Cesar de la Fuente-Nunez; Octavio Luiz Franco
Journal:  Front Microbiol       Date:  2022-04-11       Impact factor: 5.640

5.  15 years of microbial biotechnology: the time has come to think big-and act soon.

Authors:  Víctor de Lorenzo
Journal:  Microb Biotechnol       Date:  2021-12-21       Impact factor: 5.813

Review 6.  Promising Acinetobacter baumannii Vaccine Candidates and Drug Targets in Recent Years.

Authors:  Yong Chiang Tan; Chandrajit Lahiri
Journal:  Front Immunol       Date:  2022-05-26       Impact factor: 8.786

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.